Design Therapeutics, Inc.DSGNNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank17
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-54.55M
↓ 53% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-35.55M
Historical baseline
PeriodValueYoY Change
TTM$-54.55M-25.6%
2024$-43.45M+26.1%
2023$-58.82M-12.6%
2022$-52.23M-69.0%
2021$-30.91M-253.5%
2020$-8.74M-6191.4%
2019$-139000.00-